These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27645621)

  • 21. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
    Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH
    Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer.
    Kim SW; Chun M; Ryu HS; Chang SJ; Kong TW; Lee EJ; Lee YH; Oh YT
    Strahlenther Onkol; 2017 Jul; 193(7):534-542. PubMed ID: 28357468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging and staging of neuroendocrine cervical cancer.
    Elsherif S; Odisio EGLC; Faria S; Javadi S; Yedururi S; Frumovitz M; Ramalingam P; Bhosale P
    Abdom Radiol (NY); 2018 Dec; 43(12):3468-3478. PubMed ID: 29974177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
    Voong KR; Rashid A; Crane CH; Minsky BD; Krishnan S; Yao JC; Wolff RA; Skibber JM; Feig BW; Chang GJ; Das P
    Am J Clin Oncol; 2017 Dec; 40(6):555-560. PubMed ID: 26237193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impacts of ovarian preservation on the prognosis of neuroendocrine cervical carcinoma: a retrospective analysis based on machine learning.
    Xiang X; Zhang Y; Hua K; Ding J
    World J Surg Oncol; 2023 May; 21(1):146. PubMed ID: 37173713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic model for survival in patients with neuroendocrine carcinomas of the cervix: SEER database analysis and a single-center retrospective study.
    Yu C; Wu X; Zhang S; Zhang L; Zhang H; Yang H; Zhao M; Li Z
    PLoS One; 2024; 19(1):e0296446. PubMed ID: 38181016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
    Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
    J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
    Feng M; Zou J; Zhang Y; Sun L
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
    [No Abstract]   [Full Text] [Related]  

  • 29. Causes of death analysis and the prognostic model construction in neuroendocrine carcinoma of the cervix: A SEER-based study.
    Yu H; Lin Y; Lin J; Xie N; Liu L; Deng S; Sun Y
    Cancer Med; 2024 Aug; 13(15):e70066. PubMed ID: 39118477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Dilemma: Prognostic Factors and Outcome for Neuroendocrine Tumors of the Cervix.
    Abdallah R; Bush SH; Chon HS; Apte SM; Wenham RM; Shahzad MM
    Int J Gynecol Cancer; 2016 Mar; 26(3):553-60. PubMed ID: 26825841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of radiotherapy in neuroendocrine cervical cancer: SEER-based study.
    Dong M; Gu X; Ma T; Mi Y; Shi Y; Fan R
    Sci Prog; 2021; 104(2):368504211009336. PubMed ID: 33848229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice.
    Metro G; Ricciuti B; Chiari R; Baretti M; Falcinelli L; Giannarelli D; Sidoni A; Mountzios G; Crinò L; Bellezza G; Rebonato A; Ferolla P; Toschi L
    Lung Cancer; 2016 May; 95():82-7. PubMed ID: 27040856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of postoperative radiotherapy and analysis of prognostic factors in early-stage neuroendocrine carcinoma of cervix].
    Song XC; Zhang H; Zhong S; Tan XJ; Ma SQ; Jin Y; Pan LY; Wu M; Cao DY; Yang JX; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2023 Sep; 58(9):680-690. PubMed ID: 37724385
    [No Abstract]   [Full Text] [Related]  

  • 34. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
    Lim A; Sia S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PD-L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer.
    Ji X; Sui L; Song K; Lv T; Zhao H; Yao Q
    Cancer Med; 2021 Jul; 10(14):4743-4751. PubMed ID: 34076351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival and prognostic factors comparing stage IB 1 versus stage IB 2 cervical cancer treated with primary radical hysterectomy.
    Srisomboon J; Kietpeerakool C; Suprasert P; Manopanya M; Siriaree S; Charoenkwan K; Cheewakriangkrai C; Sae-Teng C
    Asian Pac J Cancer Prev; 2011; 12(7):1753-6. PubMed ID: 22126559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of time interval between radical hysterectomy with pelvic node dissection and initial adjuvant therapy on oncological outcomes of early stage cervical cancer.
    Hanprasertpong J; Jiamset I; Geater A; Leetanaporn K; Peerawong T
    J Gynecol Oncol; 2017 Jul; 28(4):e42. PubMed ID: 28541633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total hysterectomy versus radical hysterectomy in neuroendocrine cervical cancer: a SEER-database analysis.
    Zeng F; Guo P; Xia M; He M
    J Cancer Res Clin Oncol; 2024 May; 150(5):236. PubMed ID: 38710946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage disease.
    McCann GA; Boutsicaris CE; Preston MM; Backes FJ; Eisenhauer EL; Fowler JM; Cohn DE; Copeland LJ; Salani R; O'Malley DM
    Gynecol Oncol; 2013 Apr; 129(1):135-9. PubMed ID: 23357610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors and treatment comparison in small cell neuroendocrine cervical carcinoma.
    Yin ZM; Yu AJ; Wu MJ; Zhu JQ; Zhang X; Chen JH; Yuan SH; Yu H
    Eur J Gynaecol Oncol; 2014; 35(3):259-63. PubMed ID: 24984537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.